Literature DB >> 10580810

Differential effector and secretory functions of microglial cell lines derived from BCG-resistant and -susceptible congenic mouse strains.

M Puliti1, R Mazzolla, A Brozzetti, R Neglia, D Radzioch, F Bistoni, E Blasi.   

Abstract

Using congenic strains of mice susceptible (bcg(s)) or resistant (bcg(r)) to BCG, murine microglial cell lines, RR4.R (BCG-resistant) and RR8.S (BCG-susceptible), were established in vitro. Comparative studies revealed that, although phagocytic to a similar extent, RR4.R cells were more active than RR8.S cells in terms of antimycobacterial activity. Interestingly, cells of resistant genotype secreted more nitric oxide, TNF-alpha and IL-12, but less IL-6, than susceptible cells, when stimulated with IFN-gamma alone or in combination with lipopolysaccharide. Nevertheless, no significant differences were observed between the two cell lines in terms of IL-1 beta or IL-10 secretion, or on assessment of cytokine production following exposure to a massive dose of lipopolysaccharide. Overall, these data provide the first evidence that resistant/susceptible genotype influences antimycobacterial activity, NO and cytokine production in microglial cells, the prototype of cerebral macrophages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580810     DOI: 10.1016/s0165-5728(99)00127-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

1.  Intracerebral Mycobacterium bovis bacilli Calmette-Guerin infection-induced immune responses in the CNS.

Authors:  JangEun Lee; Changying Ling; Michelle M Kosmalski; Paul Hulseberg; Heidi A Schreiber; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Neuroimmunol       Date:  2009-06-16       Impact factor: 3.478

2.  A transmissible cytotoxic activity isolated from a patient with brain ischemia causes microglial cell activation and dysfunction.

Authors:  F Beretti; V Cenacchi; M Portolani; A Ardizzoni; E Blasi; C Cermelli
Journal:  Cell Mol Neurobiol       Date:  2007-03-23       Impact factor: 4.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.